TrialJournal of cancer research and clinical oncology2012

How to determine post-RCHOP therapy for risk-tailored adult patients with diffuse large B-cell lymphoma, addition of maintenance rituximab or observation: multicenter experience.

Bin-Tao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.